Deep Track Capital, LP Magenta Therapeutics, Inc. Transaction History

Deep Track Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.36 - $1.59 $849,240 - $3.75 Million	-2,359,000 Reduced 44.02%	3,000,000 $1.2 Million
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $1.25 Million - $2.56 Million	489,000 Added 10.04%	5,359,000 $15.5 Million
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $21.6 Million - $40.6 Million	4,870,000 New	4,870,000 $21.6 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.